Data, eCRF, Technical
A hitchhiker’s guide to data review in an ongoing (“live”) study – part 2: data review for interim analysis
If you are thinking of a clinical trial, you might ask yourself why and how data review for interim analysis can be a topic for a whole article. However, in a non-interventional study there are certain challenges [...]
The end of the eCRF in local language? Workflows for meeting local and global demands in your non-interventional study (NIS)
What aspects do you need to consider when planning a multi-lingual eCRF? Are regulatory requirements effective 22 November 2017 a cut-off date for the future of eCRFs in local language?
A hitchhiker’s guide to data review in an ongoing (“live”) study – part 1: data review for pharmacovigilance purposes
In a way, data review for pharmacovigilance purposes is the simplest and yet most demanding kind of data review, as time is a pressing matter in this context. The data are reviewed in different time frames according to the potential risks that arise from them [...]
Acting out? Points to consider when planning to involve actigraphy measurements into your study design
From a medical perspective, addressing concepts of physical activity and activity capacity, vital signs (like heart rate or blood pressure), and/or sleep quality in a real-time manner rather than a snap-shot at a visit, make perfect sense and could enrich the value story of novel therapies. However, when planning to involve actigraphy measurements into your study design, there are several points to be considered, including issues of validity, data transfer and data analysis [...]
To ensure a perfectly suited eCRF design many different aspects have to be taken into account also with regard to user-friendliness [...]
The electronic case report from (eCRF) played a pioneering role in the digitalization and introduction of ever new technologies into clinical research, and enjoys great popularity. Here, we would like to give you a short overview of how an eCRF develops in the course of a study.